These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12372619)

  • 1. The prolyl 4-hydroxylase inhibitor ethyl-3,4-dihydroxybenzoate generates effective iron deficiency in cultured cells.
    Wang J; Buss JL; Chen G; Ponka P; Pantopoulos K
    FEBS Lett; 2002 Oct; 529(2-3):309-12. PubMed ID: 12372619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H; Sridharan V; Wright G
    Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures by ethyl 3,4-dihydroxybenzoate.
    Majamaa K; Sasaki T; Uitto J
    J Invest Dermatol; 1987 Oct; 89(4):405-9. PubMed ID: 2822818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action.
    Sasaki T; Majamaa K; Uitto J
    J Biol Chem; 1987 Jul; 262(19):9397-403. PubMed ID: 3036858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Inhibition of Collagen Prolyl 4-Hydroxylase in Human Cells.
    Vasta JD; Andersen KA; Deck KM; Nizzi CP; Eisenstein RS; Raines RT
    ACS Chem Biol; 2016 Jan; 11(1):193-9. PubMed ID: 26535807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces haem oxygenase-1 expression in human cells through a mechanism independent of hypoxia-inducible factor-1alpha.
    Li B; Takeda K; Yokoyama S; Shibahara S
    J Biochem; 2008 Nov; 144(5):643-54. PubMed ID: 18799519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl hydroxylase inhibitor and lysyl hydroxylase inhibitor inhibit spreading of corneal epithelium.
    Saika S; Hashizume N; Okada Y; Kobata S; Yamanaka O; Uenoyama K; Ooshima A
    Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):499-502. PubMed ID: 7926886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a prolyl hydroxylase inhibitor on rabbit ocular fibroblasts.
    Saika S; Ooshima A; Yamanaka O; Tanaka S; Okada Y; Hashizume N; Ohnishi Y
    Ophthalmic Res; 1995; 27(6):335-46. PubMed ID: 8927306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hypoxia Mimetic Protocatechuic Acid Ethyl Ester Inhibits Synaptic Signaling and Plasticity in the Rat Hippocampus.
    Lanigan SM; O'Connor JJ
    Neuroscience; 2018 Jan; 369():168-182. PubMed ID: 29129792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
    Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
    FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethyl 3,4-dihydroxybenzoate (EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain.
    Singh DP; Nimker C; Paliwal P; Bansal A
    J Physiol Sci; 2016 Jul; 66(4):315-26. PubMed ID: 26649730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RETRACTED: Collagen prolyl hydroxylases are essential for breast cancer metastasis.
    Gilkes DM; Chaturvedi P; Bajpai S; Wong CC; Wei H; Pitcairn S; Hubbi ME; Wirtz D; Semenza GL
    Cancer Res; 2013 Jun; 73(11):3285-96. PubMed ID: 23539444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of collagen hydroxylation by 2,7,8-trihydroxyanthraquinone in embryonic-chick tendon cells.
    Franklin TJ; Hitchen M
    Biochem J; 1989 Jul; 261(1):127-30. PubMed ID: 2549962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
    Callapina M; Zhou J; Schnitzer S; Metzen E; Lohr C; Deitmer JW; Brüne B
    Exp Cell Res; 2005 May; 306(1):274-84. PubMed ID: 15878351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.
    Li W; Hou G; Zhou D; Lou X; Xu Y; Liu S; Zhao X
    Oncotarget; 2016 Apr; 7(16):21542-55. PubMed ID: 26934124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation of intracellular iron enhances endothelial barrier function: a role for vitamin C?
    May JM; Qu ZC
    Arch Biochem Biophys; 2010 Aug; 500(2):162-8. PubMed ID: 20510668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl hydroxylases and therapeutics.
    Smith TG; Talbot NP
    Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases.
    Cho EA; Song HK; Lee SH; Chung BH; Lim HM; Lee MK
    J Cell Biochem; 2013 Apr; 114(4):864-73. PubMed ID: 23097160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates.
    Vasta JD; Raines RT
    Bioorg Med Chem; 2015 Jul; 23(13):3081-90. PubMed ID: 26022078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration.
    Rocnik EF; Chan BM; Pickering JG
    J Clin Invest; 1998 May; 101(9):1889-98. PubMed ID: 9576753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.